SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
DURECT
(NQNM:DRRX Last Sale: 2.04 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (DRRX : $2.04)
$399,470 million Market Cap at Market Close, July 1, 2022
Employs 130.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
2 Results Way Research Report Earnings Snapshot - Last 11/03/18
Cupertino, CA 95014 Fact Sheet
Phone: (408) 777-1417 Financial Statements
Peer Comparison
Annual Reports

Felix Theeuwes, Chmn., James E. Brown, Pres./CEO, Jian Li, CFO
Developing a drug delivery system that provides long-term therapy for conditions such as diabetes, pain, arthritis, cancer, and other chronic diseases. IPO at $12 September 27, 2000. Raised $84 million, selling 7 million shares, 15% of the outstanding. Lead Manager: Morgan Stanley Dean Witter. Secondary sold 7.4 million shares at $5 November 2, 2005.
Historical Charts    Technical Analysis
No Historical Data available for DRRX

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common DRRX $2.04 $2.04 0 .0 $1.93 $2.09 471,858 $1.93 $2.09 195,818,780
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $399,470,311

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex